Our global family

In the Kowa pharmaceutical division we research, acquire, develop, licence and market pharmaceutical products and medical devices but we benefit from being part of a global family of specialists. Each division is able to use the experience of the Kowa network to ensure that processes are streamlined and constantly evolving to meet the needs of all our customers. This global network enables us to channel resources efficiently and leverage opportunities to gain visibility and presence within our chosen specialist areas.

To know more about our global family click here

“rich in knowledge and experience with a vision of a better world”

Report adverse event

Kowa routinely monitors the safety of all its medicines. This includes review of safety data from clinical studies, and collection of reports and cases of adverse events for marketed products.

Patients and Volunteers in clinical trials reporting an adverse event must contact the investigator.

For specific medical information requests please visit the relevant product page to get in touch.

For the reporting of Livazo adverse events within Europe Union please contact local distributor or Recordati

For the reporting of Livazo adverse events within Middle East and North Africa (MENA) please contact...

Contact us






    I confirm I have read and accept the terms of the Privacy policy